Peer-influenced content. Sources you trust. No registration required. This is HCN.
MedCentral
Baxdrostat significantly reduced seated systolic blood pressure compared to placebo in 796 patients, with placebo-adjusted reductions of 9.8 mmHg and 8.7 mmHg at the 2 mg and 1 mg doses respectively, without impacting cortisol levels.
Cardiology April 24th 2026
Annals of Internal Medicine
A year‑in‑review article highlights major cardiovascular themes from 2025, including evolving approaches to hypertension, myocardial infarction management, and atrial fibrillation care.
Cardiology April 21st 2026
SingleCare
Magnesium supplementation has been studied for blood pressure control, yet evidence remains mixed and effects appear modest and context‑dependent.
Ambulatory Care Nursing April 16th 2026
Verywell Health
Small studies suggest NMN supplementation may slightly affect blood pressure, but observed changes are modest and far less impactful than established therapies.
Epoch Health
“The art now is to match the intensity of treatment to both global cardiovascular risk and the patient’s blood pressure, rather than chasing a number at all costs.” – Dr. Carolyn Lam, National Heart Center of Singapore
Cardiology March 27th 2026
MDSpire News
The researchers discovered that findings among older adults reinforced the guideline shift toward personalized, risk-based care.
Cardiology March 25th 2026